Clinical Trial Update: Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus [NA]

View source ↗

Summary

This completed trial evaluated adjuvant docetaxel plus gemcitabine in patients with completely resected uterine leiomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyosarcoma

Drugs mentioned

• Gemzar (gemcitabine)
• Taxotere (docetaxel)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Uterine Leiomyosarcoma, Uterine Cancer | NA | Status: COMPLETED